Use of irinotecan for treatment of small cell carcinoma of the prostate (Q39643737)

13 September 2017

title

Use of irinotecan for treatment of small cell carcinoma of the prostate (English)

1 reference

13 September 2017

1 reference

1 reference

Wei-Lin Tung

1 reference

13 September 2017

Yuwei Wang

1 reference

13 September 2017

Dean-Mo Liu

1 reference

13 September 2017

Martin Gleave

1 reference

13 September 2017

Yuzhuo Wang

1 reference

13 September 2017

Peter W. Gout

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20949523

3 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20949523

3 August 2024

publication date

14 October 2010

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.21283

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.21283

3 August 2024

1 reference

3 August 2024

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

675-681

1 reference

Small-cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model?

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Small cell carcinoma of prostate: Effectiveness of hormonal versus chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Unusual and underappreciated: small cell carcinoma of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Imaging of small cell carcinoma of the male urogenital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Establishment of human tumor xenografts in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Stromal fibroblasts in cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Development and characterization of efficient xenograft models for benign and malignant human prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Antitumor activity of NK012 combined with cisplatin against small cell lung cancer and intestinal mucosal changes in tumor-bearing mouse after treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Combined chemotherapy with carboplatin plus irinotecan showed favorable efficacy in a patient with relapsed small cell carcinoma of the prostate complicated with meningeal carcinomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Downregulation of cystine transporter xc by irinotecan in human head and neck cancer FaDu xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Autophagy and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Apoptosis and autophagy: Targeting autophagy signalling in cancer cells -'trick or treats'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Small Cell (Neuroendocrine) Carcinoma of the Prostate: Etiology, Diagnosis, Prognosis, and Therapeutic Implications—A Retrospective Study of 30 Patients From the Rare Cancer Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21283

Neuroendocrine pathogenesis in adenocarcinoma of the prostate

21 January 2018

1 reference

Small Cell Anaplastic Carcinoma of the Prostate: A Clinical, Pathological and Immunohistological Study of 27 Patients

3 August 2024

1 reference

Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases

3 August 2024

1 reference

Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models

3 August 2024

1 reference

Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models

3 August 2024

1 reference

Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy

3 August 2024

1 reference

Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by Human Liver Carboxylesterase

3 August 2024

1 reference

A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer.

3 August 2024

1 reference

Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer.

3 August 2024

1 reference

3 August 2024

Identifiers

DOI

10.1002/PROS.21283

1 reference

13 September 2017

1 reference